Drug

Phenylephrine Hcl

58 flagged reaction(s) · 2,669 total co-reports · max PRR 159.0

Important: Reactions below are the flagged terms from this drug’s FAERS report history (min. 3 co-reports per term) — PRR/ROR indicate disproportionality in spontaneous reporting, not causation. Data from FDA FAERS via openFDA. Last recalculated: 2026-09-14.

	Reaction	Co-reports (a)	PRR	ROR	Signal
1	Fear	174	159.0	199.6	signal
2	Multi-organ Failure	112	158.1	181.9	signal
3	Renal Injury	152	125.2	152.2	signal
4	Anhedonia	121	112.9	131.5	signal
5	Injury	226	79.0	107.1	signal
6	Unevaluable Event	190	62.0	79.4	signal
7	Folliculitis	24	57.3	58.9	signal
8	Helicobacter Infection	20	48.4	49.5	signal
9	Stress	128	43.9	51.5	signal
10	Hypercholesterolaemia	17	43.8	44.7	signal
11	Wound Infection	18	40.8	41.7	signal
12	Renal Failure	219	40.4	54.0	signal
13	Renal Impairment	125	36.8	43.0	signal
14	Pemphigus	18	35.7	36.4	signal
15	Hand Deformity	18	33.9	34.6	signal
16	Cardiogenic Shock	18	31.1	31.7	signal
17	Emotional Distress	152	30.8	37.3	signal
18	Disability	24	29.9	30.7	signal
19	Joint Range Of Motion Decreased	16	29.5	30.0	signal
20	Incorrect Drug Administration Duration	32	27.6	28.7	signal
21	Pericarditis	18	26.6	27.2	signal
22	Synovitis	19	25.9	26.5	signal
23	Renal Failure Acute	44	25.2	26.5	signal
24	Back Disorder	16	24.1	24.6	signal
25	Pulmonary Fibrosis	18	23.2	23.7	signal
26	Hip Arthroplasty	14	22.7	23.1	signal
27	Irritable Bowel Syndrome	19	21.9	22.4	signal
28	Hepatotoxicity	19	21.1	21.6	signal
29	Glossodynia	19	20.9	21.4	signal
30	Joint Injury	18	20.7	21.2	signal
31	Liver Injury	20	20.4	20.8	signal
32	Fibromyalgia	19	19.3	19.7	signal
33	Joint Stiffness	19	17.8	18.2	signal
34	Anxiety	193	16.7	21.2	signal
35	Knee Arthroplasty	14	16.5	16.8	signal
36	Wound	18	15.9	16.3	signal
37	Impaired Healing	21	15.7	16.1	signal
38	Vitreous Floaters	6	15.2	15.3	signal
39	Type 2 Diabetes Mellitus	20	14.6	14.9	signal
40	Gait Inability	19	14.1	14.4	signal
41	Arthropathy	32	14.1	14.6	signal
42	Visual Acuity Reduced	18	13.2	13.5	signal
43	Contraindicated Product Administered	16	13.1	13.3	signal
44	Systemic Lupus Erythematosus	18	12.5	12.8	signal
45	Sedation	12	11.3	11.5	signal
46	Psoriatic Arthropathy	18	11.0	11.2	signal
47	Musculoskeletal Stiffness	39	11.0	11.4	signal
48	Shock	10	10.8	10.9	signal
49	Nervousness	22	10.3	10.6	signal
50	Emotional Disorder	12	9.5	9.6	signal
51	Therapeutic Product Effect Decreased	16	8.9	9.0	signal
52	Rheumatoid Arthritis	35	7.6	7.9	signal
53	Neoplasm Malignant	18	6.6	6.8	signal
54	Rebound Effect	3	6.5	6.5	signal
55	Caesarean Section	3	6.3	6.3	signal
56	Drug Dependence	32	4.8	5.0	signal
57	Wrong Technique In Drug Usage Process	5	3.3	3.4	signal
58	Dependence	3	1.3	1.3	no signal